Novartis Venture Fund
Status
ACTIVE
Global HQ
Basel, Switzerland
Countries of investment
- Israel
- USA
- Canada
- Switzerland
Investment stages
- Seed
Industries
- Pharma
- Biotechnology
- Digital Health
About
Novartis Venture Fund is a leading venture capital firm dedicated to advancing the life sciences sector by strategically investing in innovative biotechnology and biopharmaceutical companies. With a keen focus on addressing unmet patient needs, the fund supports the development of groundbreaking therapeutics that can transform healthcare. By leveraging its extensive industry expertise and network, Novartis Venture Fund aims to foster innovation and drive significant advancements in medical science, ultimately improving patient outcomes worldwide. Through its investments, the fund seeks to catalyze the growth of pioneering companies poised to make a meaningful impact in the realm of healthcare.
Novartis Venture Fund is a leading venture capital firm dedicated to advancing the life sciences sector by strategically investing in innovative biotechnology and biopharmaceutical companies. With a keen focus on addressing unmet patient needs, the fund supports the development of groundbreaking therapeutics that can transform healthcare. By leveraging its extensive industry expertise and network, Novartis Venture Fund aims to foster innovation and drive significant advancements in medical science, ultimately improving patient outcomes worldwide. Through its investments, the fund seeks to catalyze the growth of pioneering companies poised to make a meaningful impact in the realm of healthcare.
Investment Thesis
The Novartis Venture Fund was created to foster innovation, drive significant patient benefit, and generate superior returns by nurturing and investing in innovative life science companies.
Manager's Experience
With extensive experience in technology and healthcare investments, the fund manager has successfully navigated numerous growth stages, emphasizing operator-first strategies. They have built a robust portfolio with over 30 deals, focusing primarily on North American markets. Notable exits include high-profile companies that have significantly impacted their respective sectors. Their data-driven approach enables them to identify emerging trends and capitalize on thematic opportunities, positioning them as a strategic player in the investment landscape.
Team
Lauren Silverman
Robert Treiber
Nehal Patel
Markus Goebel
Luis Perez
Juliette Audet
Henry Skinner
Harry Kirsch
Giovanni Ferrara